Data / Research funding / Pediatric Cardiomyopathy

Pediatric Cardiomyopathy: 120 NIH awards ($132.9M) to 59 organizations

Name: NIH and NSF awards on Pediatric Cardiomyopathy
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

120 NIH awards ($132.9M) in the NIH spending category Pediatric Cardiomyopathy, to 59 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.

SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.

Get awards on Pediatric Cardiomyopathy Watch Pediatric Cardiomyopathy

Topic: NIH spending category

Awards

120 awards in the window.

Award	Agency	Institute or division	Fiscal year	Amount in window	Start	End	Principal investigator	Source
Hypertrophic Cardiomyopathy: Understanding the Heterogeneity of Disease Expression and Outcomes	NIH	National Heart, Lung, and Blood Institute	2021 to 2024	$5,898,403	September 1, 2021	August 31, 2025	HO, CAROLYN Y	reporter.nih.gov
BIOREPOSITORY OF HUMAN INDUCED PLURIPOTENT STEM CELLSFORCARDIOVASCULAR DISEASES (BHIPSC-CVD)- TASK A. CORE STUDY OPERATIONS	NIH	National Heart, Lung, and Blood Institute	2021 to 2024	$3,969,819	September 1, 2020	August 31, 2025	WU, JOSEPH	reporter.nih.gov
Proteomics profiling in hypertrophic cardiomyopathy and cardiac event prediction	NIH	National Heart, Lung, and Blood Institute	2021 to 2025	$3,497,937	April 1, 2021	March 31, 2027	SHIMADA, YUICHI	reporter.nih.gov
Exercise Intolerance in Non Obstructive Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2022 to 2025	$3,213,836	May 1, 2022	February 28, 2027	ABRAHAM, THEODORE P	reporter.nih.gov
Signaling To and From the Vascular/Endothelial Compartment and Progression of HCM Linked to Sarcomere Mutations	NIH	National Heart, Lung, and Blood Institute	2022 to 2025	$3,065,794	April 1, 2022	March 31, 2027	WOLSKA, BEATA M.	reporter.nih.gov
Cardiac MR-Based Risk Stratification for Heart Failure and Atrial Fibrillation in HCM	NIH	National Heart, Lung, and Blood Institute	2021 to 2024	$2,975,089	April 15, 2021	March 31, 2026	NEZAFAT, REZA	reporter.nih.gov
Structural basis of the super-relaxed state in human cardiac muscle	NIH	National Heart, Lung, and Blood Institute	2022 to 2025	$2,818,630	July 1, 2022	June 30, 2027	PADRON, RAUL	reporter.nih.gov
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling	NIH	National Heart, Lung, and Blood Institute	2022 to 2025	$2,737,027	May 1, 2012	March 31, 2027	WU, JOSEPH C.	reporter.nih.gov
Experimental and Computational Studies in Genetic Cardiomyopathies	NIH	National Heart, Lung, and Blood Institute	2022 to 2025	$2,674,553	May 1, 2022	April 30, 2027	MOUSSAVI-HARAMI, FARID	reporter.nih.gov
ERK1/2-Integrin Signaling in Desmosome-Dyad Crosstalk	NIH	National Heart, Lung, and Blood Institute	2021 to 2024	$2,470,019	September 1, 2021	August 31, 2025	SONG, LONG-SHENG	reporter.nih.gov
Myosin Movement In Vitro - Molecular Characterization	NIH	National Institute of General Medical Sciences	2021 to 2024	$2,395,665	April 1, 1984	January 31, 2026	SPUDICH, JAMES	reporter.nih.gov
Control of Breathing and Pompe Disease	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021 to 2024	$2,360,520	February 15, 2007	April 30, 2026	BYRNE, BARRY J	reporter.nih.gov
Targeting the genotype to phenotype link in HCM as a therapeutic strategy	NIH	National Heart, Lung, and Blood Institute	2021 to 2024	$2,339,175	March 1, 2021	February 28, 2026	MERCOLA, MARK	reporter.nih.gov
Determining Potential Mechanisms of Worse Outcomes in Black HCM Patients	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$2,260,466	August 10, 2023	May 31, 2028	CRESCI, SHARON	reporter.nih.gov
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine	NIH	National Heart, Lung, and Blood Institute	2021 to 2025	$2,249,910	July 1, 2018	January 31, 2027	KARAKIKES, IOANNIS	reporter.nih.gov
Transcriptomics, pathobiology, and cardiac event in hypertrophic cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$2,173,242	June 1, 2023	May 31, 2028	SHIMADA, YUICHI	reporter.nih.gov
Deciphering the Endothelial Cell-Cardiomyocyte Crosstalk in LMNA Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2021 to 2025	$2,153,289	September 15, 2021	March 31, 2026	SAYED, NAZISH	reporter.nih.gov
Missense Variants in Myosin Binding Protein C that Cause Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$2,100,429	September 1, 2023	August 31, 2027	DAY, SHARLENE M	reporter.nih.gov
Activity and therapeutic antagonism of the TP receptor in cardiomyopathy of muscular dystrophy	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$2,092,461	July 1, 2023	June 30, 2027	WEST, JAMES D	reporter.nih.gov
Mechanochemistry of myosin mutations that cause cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2021 to 2024	$2,064,970	June 1, 2021	May 31, 2026	OSTAP, E. MICHAEL	reporter.nih.gov
Structure function relationships from deep mutational scanning in human cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2021 to 2023	$2,035,543	January 1, 2020	December 31, 2024	ASHLEY, EUAN A	reporter.nih.gov
Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$2,008,113	March 10, 2015	June 30, 2024	WU, JOSEPH C.	reporter.nih.gov
Uncovering Molecular Targets for Arrhythmogenic Cardiomyopathy Therapeutics	NIH	National Heart, Lung, and Blood Institute	2022 to 2025	$1,975,000	April 1, 2022	March 31, 2027	SHEIKH, FARAH	reporter.nih.gov
Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2023 to 2024	$1,971,939	May 1, 2023	April 30, 2026	LEVIN, HOWARD	reporter.nih.gov
Biomaterial Platforms to Model the Role of Mechanical Overload in MYBPC3-Linked Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2021 to 2025	$1,955,125	September 1, 2021	August 31, 2027	HUEBSCH, NATHANIEL	reporter.nih.gov
Screen and functional validation of Pediatric Cardiomyopathy genetic variants in Drosophila	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2023 to 2025	$1,944,551	April 4, 2023	March 31, 2028	HAN, ZHE	reporter.nih.gov
High-Intensity Ultrasound Ablation for Septal Reduction Therapy of Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$1,890,310	September 9, 2023	February 28, 2027	NAZER, BABAK	reporter.nih.gov
A Precision Medicine Approach to Arrhythmogenic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2021 to 2023	$1,873,937	January 19, 2019	December 31, 2024	CARRUTH, ERIC DAVID	reporter.nih.gov
Uncovering The Mechanogenomic Basis For Cardiac Plasticity	NIH	National Heart, Lung, and Blood Institute	2021 to 2025	$1,825,774	July 1, 2018	May 31, 2028	DAVIS, JENNIFER MICHELLE	reporter.nih.gov
Ferroptosis in the Heart: Iron Calcium Crosstalk and Compartmentalization	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$1,751,600	December 25, 2021	November 30, 2026	XIE, LAI-HUA	reporter.nih.gov
Human Disease-Specific Induced Pluripotent Stem Cells For Preclinical Drug Testing and Drug Discovery	NIH	National Heart, Lung, and Blood Institute	2022	$1,728,439	March 4, 2022	February 28, 2023	BUI, LYNNE A	reporter.nih.gov
Modulation of heart function by Muscle LIM protein-mediated mechanotransduction	NIH	National Heart, Lung, and Blood Institute	2022 to 2025	$1,675,000	July 1, 2022	June 30, 2026	QYANG, YIBING	reporter.nih.gov
3D Bioprinted Human Model of Duchenne Muscular Dystrophy (DMD) Cardiomyopathy to Study Disease Progression with Imposed Force and Precise Gene Editing	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$1,651,448	July 1, 2023	April 30, 2028	KAMDAR, FORUM D	reporter.nih.gov
Targeting Energetics to Improve Outcomes in Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$1,629,945	April 1, 2024	March 31, 2028	LUPTAK, IVAN	reporter.nih.gov
Hyperpolarized 13C MRI of Cardiac Metabolic Remodeling in Heart Disease	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$1,614,450	September 1, 2024	June 30, 2028	LARSON, PEDER ERIC ZUFALL	reporter.nih.gov
The interaction of myosin and the thin filament: how mutations cause allosteric dysfunction and their connection to genetic cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2021 to 2023	$1,611,267	December 15, 2010	July 31, 2025	TARDIFF, JIL C	reporter.nih.gov
Mechanotransduction by Melusin in Cardiac Hypertrophy	NIH	National Heart, Lung, and Blood Institute	2021 to 2023	$1,594,551	July 1, 2020	June 30, 2025	SNIADECKI, NATHAN JOHN	reporter.nih.gov
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$1,576,689	January 23, 2024	December 31, 2028	SOSLOW, JONATHAN HARVEY	reporter.nih.gov
Mechanisms of calcium-induced arrhythmias in arrhythmogenic right ventricular cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2022 to 2025	$1,555,000	January 1, 2022	December 31, 2026	ALVARADO, FRANCISCO J	reporter.nih.gov
Cardiac MRI Increases Accuracy and Decreases Risk of Evaluation of Children with Cardiomyopathy and Cardiac Transplantation	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$1,533,577	February 15, 2019	April 8, 2022	OLIVIERI, LAURA J	reporter.nih.gov
Development of early metabolic imaging biomarkers for muscular dystrophy and cardiomyopathy in patients	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$1,514,698	June 15, 2024	April 30, 2028	PARK, JAE MO	reporter.nih.gov
FHOD3 Regulation of Autophagy Pathway in Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$1,482,096	August 22, 2024	May 31, 2028	HUGGINS, GORDON S	reporter.nih.gov
Risk Alleles in Protein Quality Control Genes as Modifiers of Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$1,472,559	December 14, 2023	November 30, 2027	DAY, SHARLENE M	reporter.nih.gov
Machine Learning Guided Precision Genetic Testing for Identification of Monogenic Cardiovascular Disorders	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$1,462,209	July 1, 2024	May 31, 2028	SHAH, SVATI H.	reporter.nih.gov
MicroRNA Control of Dilated Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$1,452,730	December 12, 2023	September 20, 2025	MERCOLA, MARK	reporter.nih.gov
Leveraging Large-Scale Biobanks to Discover and Define Rare Variant Effects in Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$1,452,595	August 1, 2024	July 31, 2028	WELLS, QUINN STANTON	reporter.nih.gov
IND-enabling safety and toxicity testing of a subcutaneous formulation of the PTP1B inhibitor MSI-1436, a novel strategy for treating fatal cardiomyopathy in Duchenne muscular dystrophy patients	NIH	National Heart, Lung, and Blood Institute	2024	$1,358,179	September 20, 2024	September 19, 2025	STRANGE, KEVIN	reporter.nih.gov
Multi-scale modeling of inherited pediatric cardiomyopathies	NIH	National Heart, Lung, and Blood Institute	2021	$1,355,405	September 1, 2017	January 31, 2023	PARKER, KEVIN KIT	reporter.nih.gov
SGLT-inhibitors in patients with hypertrophic cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$1,352,130	September 1, 2023	August 31, 2027	DAY, SHARLENE M	reporter.nih.gov
iPRISM (Imaging-enhanced Prediction of RIsk for Sudden cardiac death in hcM)	NIH	National Heart, Lung, and Blood Institute	2025	$1,289,113	August 15, 2025	May 31, 2029	BALAJI, SESHADRI	reporter.nih.gov
Evaluation of the AMPK-BACH1-NRF2 Axis as a Therapeutic Target for Inherited DCM	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$1,204,420	July 16, 2024	April 30, 2028	MERCOLA, MARK	reporter.nih.gov
Regulation of cardiac power output in health and disease	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$1,070,114	April 1, 2018	March 31, 2024	GREENBERG, MICHAEL J	reporter.nih.gov
The role of RNA-binding protein Lin28a in hypertrophic cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$1,046,368	July 15, 2019	June 30, 2024	LIU, JIANDONG	reporter.nih.gov
Mechanistic Insights into The Role of Microtubule Organizing Centers on Cardiomyocyte Structure and Function	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$1,028,631	July 1, 2023	May 31, 2027	HONG, CHARLES C	reporter.nih.gov
Modeling myosin mechanobiology towards understanding the mechanisms of hypertrophic cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$850,599	February 1, 2023	January 31, 2027	VANDER ROEST, ALISON SCHROER	reporter.nih.gov
Targeting Energetics to Improve Outcomes in Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2022	$817,568	September 16, 2022	August 31, 2024	LUPTAK, IVAN	reporter.nih.gov
Prognostic Significance of microRNA Expression in Children with Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2021	$799,064	February 17, 2018	January 31, 2024	LIPSHULTZ, STEVEN EDWARD	reporter.nih.gov
Unraveling The Mechanism of Heart Failure in Hypertrophic Cardiomyopathy with Exercise CMR	NIH	National Heart, Lung, and Blood Institute	2025	$777,258	February 25, 2025	January 31, 2030	NEZAFAT, REZA	reporter.nih.gov
Targeting Pannexin 1 as a Novel Mechanism for Arrhythmia and Fibrosis in Duchenne Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2021 to 2025	$741,945	January 7, 2021	December 31, 2025	RAUCCI, FRANK J	reporter.nih.gov
Molecular Basis for cMyBP-C HCM variants	NIH	National Heart, Lung, and Blood Institute	2025	$730,764	June 1, 2025	March 31, 2029	STELZER, JULIAN	reporter.nih.gov
Discovery of Novel Genetic Variants Underlying Unexplained Hypertrophic Cardiomyopathy by Whole Genome Sequencing, RNA-seq and iPSC modeling	NIH	National Heart, Lung, and Blood Institute	2021 to 2024	$676,944	February 15, 2020	January 31, 2025	HAGHIGHI, ALIREZA	reporter.nih.gov
Pathogenic mechanisms of myosin binding protein C missense variants within hypertrophic cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2022 to 2025	$669,600	July 1, 2022	June 30, 2027	THOMPSON, ANDREA DOOLEY	reporter.nih.gov
Chemically inducible split base editors for precise and controllable in vivo genome editing	NIH	National Heart, Lung, and Blood Institute	2025	$667,704	February 1, 2025	November 30, 2028	GAO, XUE	reporter.nih.gov
Early Onset Diastolic Dysfunction in HCM: Identifying New Mechanisms and Targets	NIH	National Heart, Lung, and Blood Institute	2025	$618,045	December 15, 2024	November 30, 2028	TARDIFF, JIL C	reporter.nih.gov
AAV therapies for TNNT2-associated cardiac disorders	NIH	National Heart, Lung, and Blood Institute	2025	$611,014	September 1, 2025	July 31, 2027	HINSON, JOHN TRAVIS	reporter.nih.gov
Ferroptosis in the Heart: Iron Calcium Crosstalk and Compartmentalization	NIH	National Heart, Lung, and Blood Institute	2022	$603,528	December 25, 2021	November 30, 2022	XIE, LAI-HUA	reporter.nih.gov
High-Intensity Ultrasound Ablation for Septal Reduction Therapy of Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2022	$602,903	March 15, 2022	September 30, 2022	NAZER, BABAK	reporter.nih.gov
Cardiac Sensory and Sympathetic Nerve Dysregulation in Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2025	$589,998	September 1, 2025	August 31, 2028	LARSON, ROBERT ARNOLD	reporter.nih.gov
Comprehensive Analysis of Allelic, Cellular and Molecular Heterogeneity in Human 3-Dimensional Cardiac Microtissues with MYH7 Mutations	NIH	National Heart, Lung, and Blood Institute	2021	$539,937	July 1, 2018	June 30, 2024	HINSON, JOHN TRAVIS	reporter.nih.gov
Improving the Detection of Hypertrophic Cardiomyopathy Using Machine Learning Applied to Electronic Health Record Data	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$518,576	September 1, 2023	August 31, 2028	REZA, NOSHEEN	reporter.nih.gov
Probing the Molecular Mechanisms of Diastolic Dysfunction Using Patient-Specific Stem Cells	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$497,988	August 11, 2023	July 31, 2028	STAUDT, DAVID WELLS	reporter.nih.gov
Cardiac MRI increases accuracy and decreases risk of evaluation of children with cardiomyopathy and cardiac transplantation	NIH	National Heart, Lung, and Blood Institute	2023	$486,915	February 15, 2019	November 30, 2025	OLIVIERI, LAURA J	reporter.nih.gov
Bridging the gap between mutation & cellular effects: Defining the mechanisms of hypertrophic cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2021 to 2023	$486,045	September 20, 2019	July 31, 2024	KAWANA, MASATAKA	reporter.nih.gov
Gene Therapy Design Principles for Duchenne Muscular Dystrophy	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$476,731	September 1, 2023	August 31, 2028	EGUCHI, ASUKA	reporter.nih.gov
Progressive loading of a human dystrophic cardiomyopathy 3D model to mimic disease and evaluate therapeutic	NIH	National Heart, Lung, and Blood Institute	2022 to 2024	$465,872	September 1, 2022	August 31, 2025	KAMDAR, FORUM D	reporter.nih.gov
A New Paradigm to Incorporate Protein Dynamics into Targeted Small Molecule Design for Sarcomeric Cardiomyopathies: A Proof of Concept for Thin Filament Therapeutics	NIH	National Heart, Lung, and Blood Institute	2021	$465,498	January 1, 2018	December 31, 2022	TARDIFF, JIL C	reporter.nih.gov
CHERISH (duCHennE caRdiomyopathy mItigation Sglt2 inHibitor)	NIH	National Heart, Lung, and Blood Institute	2025	$444,838	September 4, 2025	August 31, 2027	MARKHAM, LARRY W.	reporter.nih.gov
A Controlled Septal Ablation for Inoperable Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2022	$433,120	September 1, 2022	August 31, 2025	LIAO, JUN	reporter.nih.gov
Investigations of Pathologic Remodeling Using Pediatric Heart Failure Serum	NIH	National Heart, Lung, and Blood Institute	2021 to 2024	$428,109	December 1, 2019	November 30, 2025	SUCHAROV, CARMEN C	reporter.nih.gov
Copper Homeostasis in Mammals	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$421,496	February 1, 2001	February 28, 2023	MATSUNAMI, HIROAKI	reporter.nih.gov
Profiles of Myocardial Metabolism in "Gray-Zone" Athletic Left Ventricular Hypertrophy versus Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$400,976	January 25, 2018	November 30, 2022	WASFY, MEAGAN M	reporter.nih.gov
Molecular mechanisms underlying cardiac sodium channelopathy	NIH	National Heart, Lung, and Blood Institute	2021	$397,594	July 1, 2017	June 30, 2022	YAZAWA, MASAYUKI	reporter.nih.gov
Molecular pathways controlling cardiac gene expression	NIH	National Heart, Lung, and Blood Institute	2021	$397,500	July 20, 1998	June 30, 2023	MOLKENTIN, JEFFERY D	reporter.nih.gov
Uncovering New Functions of CSN6 in Cardiac Desmosomal Biology and Disease	NIH	National Heart, Lung, and Blood Institute	2021	$395,000	August 1, 2018	July 31, 2023	SHEIKH, FARAH	reporter.nih.gov
Elucidation of the role of human genetic factors underlying viral myocarditis susceptibility	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$380,676	July 6, 2018	June 30, 2023	KONTOROVICH, AMY R.	reporter.nih.gov
Top-Down Proteomics of Myofilaments in Heart Failure	NIH	National Heart, Lung, and Blood Institute	2021	$372,960	August 5, 2011	November 30, 2022	GE, YING	reporter.nih.gov
SGLT-inhibitors in patients with hypertrophic cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2023	$370,904	September 1, 2023	August 31, 2024	DAY, SHARLENE M	reporter.nih.gov
Moonlighting in Mitochondria: A Non-Canonical Role for Cardiac Troponin I in Inherited Cardiomyopathies	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$331,344	August 1, 2024	July 31, 2029	ELEZABY, ALY	reporter.nih.gov
Modeling myosin mechanobiology towards understanding the mechanisms of hypertrophic cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$328,576	August 15, 2021	January 31, 2023	VANDER ROEST, ALISON SCHROER	reporter.nih.gov
MUSICO: An in silico platform for evaluating the effects of disease and drug effectiveness in HCM and DCM cardiomyopathies	NIH	National Heart, Lung, and Blood Institute	2025	$297,720	July 15, 2025	July 14, 2027	MIJAILOVICH, SRBOLJUB M	reporter.nih.gov
3-Dimensional virtual ventricles to design precision therapies in hypertrophic cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$286,060	April 1, 2021	June 30, 2022	MORENO, JONATHAN	reporter.nih.gov
C-type natriuretic peptide in hypertrophic cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$261,036	December 15, 2023	November 30, 2026	ARMSTRONG, DAVID WILLIAM JOHN	reporter.nih.gov
CardioTwin HCM: A non-genetic early diagnostic test for hypertrophic cardiomyopathy risk	NIH	National Heart, Lung, and Blood Institute	2022	$259,609	March 15, 2022	February 29, 2024	RUPERT, CASSADY E.	reporter.nih.gov
Non-contrast 3D T1p Mapping for Myocardial Fibrosis Quantification of Pediatric Cardiomyopathy Patients	NIH	National Heart, Lung, and Blood Institute	2025	$248,970	December 9, 2024	November 30, 2027	GUNASEKARAN, SUVAI	reporter.nih.gov
Exercise-induced cardiac adaptation in hypertrophic cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2022 to 2023	$245,156	July 1, 2022	August 31, 2024	LINDHOLM, MALENE	reporter.nih.gov
Dissecting the mechanisms of how MYH7 S2 mutations lead to genetic hypertrophic cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2022 to 2024	$213,430	July 1, 2022	June 30, 2025	LOIBEN, ALEXANDER	reporter.nih.gov
Non-contrast 3D T1p Mapping for Myocardial Fibrosis Quantification of Pediatric Cardiomyopathy Patients	NIH	National Heart, Lung, and Blood Institute	2022 to 2023	$194,607	March 1, 2022	December 6, 2024	GUNASEKARAN, SUVAI	reporter.nih.gov
Mechanical and Metabolic Pathways Underlying MYBPC3 Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2025	$167,400	May 15, 2025	April 30, 2030	MEISNER, JOSHUA K	reporter.nih.gov
Innovative natriuretic peptide-based therapy for hypertrophic cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2022 to 2023	$166,050	September 25, 2022	August 24, 2024	ARMSTRONG, DAVID WILLIAM JOHN	reporter.nih.gov
A multi-modal approach for efficient, point-of-care screening of hypertrophic cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2023 to 2024	$165,684	September 1, 2023	August 31, 2026	OIKONOMOU, EVANGELOS	reporter.nih.gov
Precision Cardiovascular Medicine for Multi-Ethnic Populations	NIH	National Heart, Lung, and Blood Institute	2021	$161,551	May 1, 2018	December 31, 2021	MANRAI, ARJUN KUMAR	reporter.nih.gov
Epigenetic control of pathologic cardiac remodeling	NIH	National Heart, Lung, and Blood Institute	2021	$160,812	April 1, 2017	March 31, 2022	BURKE, MICHAEL A	reporter.nih.gov
Modeling Endothelial Dysfunction in LMNA-related Dilated Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2021	$157,793	January 6, 2017	December 31, 2021	SAYED, NAZISH	reporter.nih.gov
Precision Cardiovascular Medicine for Multi-Ethnic Populations	NIH	National Heart, Lung, and Blood Institute	2022	$155,444	March 7, 2022	April 30, 2024	MANRAI, ARJUN KUMAR	reporter.nih.gov
Mechanisms of cardiomyocyte dysfunction due to the E258K-MYBPC3 mutation modeled in patient-derived cardiomyocytes	NIH	National Heart, Lung, and Blood Institute	2022 to 2024	$137,366	September 30, 2022	September 29, 2025	STECZINA, SONETTE	reporter.nih.gov
Spatiotemporal and Deep Learning Analysis of Cardiac Imaging for Predictive Risk Stratification in Duchenne Muscular Dystrophy	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$130,736	August 5, 2022	August 4, 2026	EARL, CONNER	reporter.nih.gov
Investigating the Time-Dependent Reversibility of DCM-Induced Epigenetic, Matrix, and Functional Remodeling	NIH	National Heart, Lung, and Blood Institute	2022 to 2024	$128,021	September 16, 2022	September 15, 2025	REICHARDT, ISABELLA	reporter.nih.gov
High-Throughput Studies of MYH7 Variant Cardiomyocytes to Identify Pathogenic Variants and Factors Governing Variable Expressivity of Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2025	$126,306	December 20, 2024	November 30, 2026	FRIEDMAN, CLAYTON E	reporter.nih.gov
Hypertrophic cardiomyopathy-induced paracrine signaling and stromal activation	NIH	National Heart, Lung, and Blood Institute	2021 to 2023	$101,367	June 1, 2021	August 24, 2023	EWOLDT, JOURDAN	reporter.nih.gov
Vascular Remodeling is a Crucial Factor in the Progression of Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$100,592	April 1, 2020	February 28, 2023	MARSZALEK, RICHARD	reporter.nih.gov
Serotonin-2B receptor in hypertrophic cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$98,512	January 1, 2024	December 31, 2027	LIVINGSTON, WILLIAM BRYAN	reporter.nih.gov
Spatiotemporal and Deep Learning Analysis of Cardiac Imaging for Predictive Risk Stratification in Duchenne Muscular Dystrophy	NIH	National Heart, Lung, and Blood Institute	2022 to 2023	$89,498	August 5, 2022	March 31, 2024	EARL, CONNER	reporter.nih.gov
The Role of Yes Associated Protein (YAP) in Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2022 to 2024	$87,829	February 1, 2022	March 31, 2024	CHIRIKIAN, ORLANDO	reporter.nih.gov
Blunting of the Myofilament Beta-Adrenergic Response in HCM: Structural-Dynamic Mechanisms	NIH	National Heart, Lung, and Blood Institute	2023 to 2024	$85,044	August 15, 2023	August 14, 2025	CASTILLO, ROMI L	reporter.nih.gov
Base Editing Gene Correction of Pathogenic MYH7 Mutations in Models of Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2022 to 2023	$83,233	September 1, 2022	August 31, 2024	CHAI, ANDREAS C	reporter.nih.gov
Elucidating Molecular Mechanisms of Hypertrophic Cardiomyopathy using Nano-Engineered Synthetic Myosin Thick Filaments	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$77,566	February 18, 2019	February 17, 2023	TOUMA, ANJA	reporter.nih.gov
Structure, Function and Drug Treatment of the Native Cardiac Sarcomere in Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2025	$75,520	April 1, 2025	March 31, 2028	WILBURN, DYLAN THOMAS	reporter.nih.gov
Targeting TRAPPC11 as a therapeutic in inherited dilated cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2025	$75,052	September 30, 2025		STURGILL, SARAH LOUISE	reporter.nih.gov
A single prime editing strategy for correcting diverse mutations responsible for RBM20-associated dilated cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$68,176	September 1, 2024	August 31, 2027	GASTON, NICHOLAS	reporter.nih.gov
Mutation-Specific Calmodulin Kinase II Activation in Hypertrophic Cardiomyopathy	NIH	National Heart, Lung, and Blood Institute	2025	$42,171	June 1, 2025	May 31, 2027	HAUCK, GARRETT TURNER	reporter.nih.gov

Organizations

Organization	Place	NIH awards	NIH amount	NSF amount
Stanford University	Stanford, CA	17	$24.7 million	$0
University of Washington	Seattle, WA	8	$8.6 million	$0
University of Pennsylvania	Philadelphia, PA	7	$8.5 million	$0
Brigham and Women's Hospital	Boston, MA	2	$6.6 million	$0
Columbia University Health Sciences	New York, NY	3	$6.1 million	$0
Washington University	Saint Louis, MO	4	$5.6 million	$0
Vanderbilt University Medical Center	Nashville, TN	5	$5.5 million	$0
University of California, San Francisco	San Francisco, CA	2	$4.8 million	$0
Beth Israel Deaconess Medical Center	Boston, MA	2	$3.8 million	$0
University of Illinois at Chicago	Chicago, IL	2	$3.2 million	$0
Univ of Massachusetts Med SCH Worcester	Worcester, MA	2	$2.9 million	$0
University of Arizona	Tucson, AZ	5	$2.8 million	$0
University of Iowa	Iowa City, IA	1	$2.5 million	$0
Boston Medical Center	Boston, MA	2	$2.4 million	$0
University of California, San Diego	La Jolla, CA	2	$2.4 million	$0
University of Florida	Gainesville, FL	1	$2.4 million	$0
University of Minnesota	Minneapolis, MN	3	$2.2 million	$0
Coridea, LLC	New York, NY	1	$2 million	$0
University of Maryland Baltimore	Baltimore, MD	1	$1.9 million	$0
University of Wisconsin-Madison	Madison, WI	2	$1.9 million	$0
Oregon Health & Science University	Portland, OR	2	$1.9 million	$0
Duke University	Durham, NC	2	$1.9 million	$0
Geisinger Clinic	Danville, PA	1	$1.9 million	$0
Yale University	New Haven, CT	2	$1.8 million	$0
Rutgers Biomedical and Health Sciences	Newark, NJ	1	$1.8 million	$0
Khloris Biosciences, Inc.	South San Francisco, CA	1	$1.7 million	$0
University of Michigan at Ann Arbor	Ann Arbor, MI	3	$1.7 million	$0
Ut Southwestern Medical Center	Dallas, TX	3	$1.7 million	$0
Children's Research Institute	Washington, DC	1	$1.5 million	$0
Tufts Medical Center	Boston, MA	1	$1.5 million	$0
Revidia Therapeutics, INC	Ellsworth, ME	1	$1.4 million	$0
Harvard University	Cambridge, MA	1	$1.4 million	$0
University of Connecticut SCH of Med/dnt	Farmington, CT	2	$1.2 million	$0
Univ of North Carolina Chapel Hill	Chapel Hill, NC	1	$1 million	$0
Henry Ford Health + Michigan State University Health Sciences	East Lansing, MI	1	$1 million	$0
SUNY at Buffalo	Amherst, NY	1	$799,064	$0
Virginia Commonwealth University	Richmond, VA	1	$741,945	$0
Case Western Reserve University	Cleveland, OH	1	$730,764	$0
Rbhs-New Jersey Medical School	Newark, NJ	1	$603,528	$0
Michigan Technological University	Houghton, MI	1	$589,998	$0
Indiana University Indianapolis	Indianapolis, IN	2	$575,574	$0
University of Pittsburgh at Pittsburgh	Pittsburgh, PA	1	$486,915	$0
University of California-Irvine	Irvine, CA	1	$476,731	$0
University of Texas at Arlington	Arlington, TX	1	$433,120	$0
University of Colorado Denver	Aurora, CO	1	$428,109	$0
Massachusetts General Hospital	Boston, MA	1	$400,976	$0
Cincinnati Childrens Hosp Med CTR	Cincinnati, OH	1	$397,500	$0
Icahn School of Medicine at Mount Sinai	New York, NY	1	$380,676	$0
Filamentech. Inc.	Middletown, DE	1	$297,720	$0
Propria LLC	Branford, CT	1	$259,609	$0
Cedars-Sinai Medical Center	Los Angeles, CA	1	$248,970	$0
Northwestern University at Chicago	Chicago, IL	1	$194,607	$0
Boston Children's Hospital	Boston, MA	1	$161,551	$0
Emory University	Atlanta, GA	1	$160,812	$0
Harvard Medical School	Boston, MA	1	$155,444	$0
Trustees of Boston University	Boston, MA	1	$101,367	$0
Vanderbilt University	Nashville, TN	1	$98,512	$0
Purdue University	West Lafayette, IN	1	$89,498	$0
University of California-Santa Barbara	Santa Barbara, CA	1	$87,829	$0

Funding by fiscal year

Fiscal year	NIH awards	NIH amount	NSF amount
2025	59	$29,708,793	$0
2024	63	$32,038,701	$0
2023	58	$25,462,290	$0
2022	56	$24,357,736	$0
2021	44	$21,333,119	$0

Open federal funding opportunities

From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.

Open opportunity	Number	Agency	Listing	Closes	Award ceiling	Why it matches
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)	PA-24-182	NIH		May 8, 2027	Not listed	Notice number printed on 1 award here
Emerging Global Leader Award (K43 Independent Clinical Trial Required)	PAR-24-295	NIH	93.837	December 3, 2026	Not listed	Same assistance listing 93.837 as 115 awards here
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)	PAR-24-296	NIH	93.837	December 3, 2026	Not listed	Same assistance listing 93.837 as 115 awards here
NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)	RFA-OD-24-011	NIH	93.837	December 4, 2026	Not listed	Same assistance listing 93.837 as 115 awards here
Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)	PAR-27-039	NIH	93.837	January 5, 2027	Not listed	Same assistance listing 93.837 as 115 awards here
Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)	PAR-27-040	NIH	93.837	January 5, 2027	Not listed	Same assistance listing 93.837 as 115 awards here
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)	PAR-24-214	NIH	93.837	January 7, 2027	$375,000	Same assistance listing 93.837 as 115 awards here
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)	PAR-25-379	NIH	93.837	January 7, 2027	Not listed	Same assistance listing 93.837 as 115 awards here
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)	PAR-25-025	NIH	93.837	February 3, 2027	$1.5 million	Same assistance listing 93.837 as 115 awards here
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)	PAR-25-026	NIH	93.837	February 3, 2027	Not listed	Same assistance listing 93.837 as 115 awards here
Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)	PAR-27-125	NIH	93.837	February 16, 2027	Not listed	Same assistance listing 93.837 as 115 awards here
Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)	RFA-DK-27-108	NIH	93.837	March 10, 2027	$500,000	Same assistance listing 93.837 as 115 awards here
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)	PAR-25-032	NIH	93.837	March 16, 2027	Not listed	Same assistance listing 93.837 as 115 awards here
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)	PA-27-100	NIH	93.837	April 5, 2027	Not listed	Same assistance listing 93.837 as 115 awards here
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)	PA-27-102	NIH	93.837	April 5, 2027	Not listed	Same assistance listing 93.837 as 115 awards here
Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed)	RFA-OD-25-003	NIH	93.837	April 9, 2027	$200,000	Same assistance listing 93.837 as 115 awards here
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)	RFA-HL-26-002	NIH	93.837	April 28, 2027	Not listed	Same assistance listing 93.837 as 115 awards here
NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)	RFA-HL-26-003	NIH	93.837	April 28, 2027	Not listed	Same assistance listing 93.837 as 115 awards here
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)	PA-24-175	NIH	93.837	May 7, 2027	Not listed	Same assistance listing 93.837 as 115 awards here
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)	PA-24-176	NIH	93.837	May 7, 2027	Not listed	Same assistance listing 93.837 as 115 awards here

Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.